squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma#411384ClinicalTrials.gov
• Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck#448279ClinicalTrials.gov
• Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)#848672ClinicalTrials.gov
• Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil#850926ClinicalTrials.gov
• PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma#863411ClinicalTrials.gov
• Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy#900806ClinicalTrials.gov
• Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer#854755ClinicalTrials.gov
• Laryngeal Preservation in Pyriform Sinus Carcinoma#858244ClinicalTrials.gov
• Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)#67862ClinicalTrials.gov
• Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).#226240ClinicalTrials.gov
• Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)#369840ClinicalTrials.gov
• Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma#806702ClinicalTrials.gov
• The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy#806824ClinicalTrials.gov
• Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma#852222ClinicalTrials.gov
• A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma#853221ClinicalTrials.gov
• Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma#873972ClinicalTrials.gov
• Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the Anus#877581ClinicalTrials.gov
• AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma#887654ClinicalTrials.gov
• Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma#898338ClinicalTrials.gov
• Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer#859942ClinicalTrials.gov
• Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN#307446ClinicalTrials.gov
• Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma#895433ClinicalTrials.gov
• Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus#830618ClinicalTrials.gov
• Vitamin-D Receptor in Laryngeal Squamous Cell Carcinoma#812215ClinicalTrials.gov
• Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma#123466ClinicalTrials.gov
• Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC#184833ClinicalTrials.gov
• Current Preoperative Management of Vulvar Squamous Cell Carcinoma: An Overview#221856IRIS
• Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma#249679ClinicalTrials.gov
• Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2#812641ClinicalTrials.gov
• Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years#827177ClinicalTrials.gov
• Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)#834414ClinicalTrials.gov
• Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus#842132ClinicalTrials.gov
• Infiltration Pattern of Locally Advanced ESCC#847186ClinicalTrials.gov
• Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx#863985ClinicalTrials.gov
• Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma#407731ClinicalTrials.gov
• A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma#884064ClinicalTrials.gov
• Deep sequencIng in Cutaneous Squamous CEll caRciNomas#836572ClinicalTrials.gov
• Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC#857479ClinicalTrials.gov
• A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision#253082ClinicalTrials.gov
• Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer#884786ClinicalTrials.gov
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer#851424ClinicalTrials.gov
• Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies#842681ClinicalTrials.gov
• The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124#858111ClinicalTrials.gov
• Study of TVEC in Patients With Cutaneous Squamous Cell Cancer#846604ClinicalTrials.gov
• Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer#303731ClinicalTrials.gov
• PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy#801012ClinicalTrials.gov
• CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma#127583ClinicalTrials.gov
• Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma#152418ClinicalTrials.gov
• Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.#268018ClinicalTrials.gov
• Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma#283045ClinicalTrials.gov